Factor’s culture is one of curiosity and discovery, driven by a desire to invent new technologies to treat disease and improve health. At Factor, we strive to immerse our scientists in an environment that provides all of the resources they need to be successful. In this environment, we have assembled a vibrant and diverse community of people collaborating to produce outstanding results.
Mission, Vision, & Values
We founded Factor Bioscience to develop new technologies in a little-explored area that we believed had enormous potential: messenger RNA ("mRNA"). Our goal is to unleash the potential of mRNA to treat disease and improve health.
At Factor, we support a model of unlimited discovery. We believe that breakthroughs arise when scientists are given the freedom and resources to pursue their ideas. At Factor, science is our business.
Patience: At Factor, our projects are not organized around artificial timelines. We understand that science is often unpredictable, and success requires committing to explore potentially world-changing ideas.
When Jasmine Harris graduated with a bachelor’s degree in Materials Science and Engineering from MIT and began her job search, she hadn't taken a biology course since her freshman year. She was seeking a research position that would give her independence, responsibility, and allow her to learn a new scientific discipline. And, while Jasmine had worked for two years in a biological conservation lab in high school, she was determined not to pursue a career in biology. "I'm also very stubborn," she said. “I never wanted to fit into expectations based on my gender identity. I felt the need to defy expectations and show I could do anything my male peers could do. So, biology was out because that’s the science I was told to go into,” she stated.
Franklin Kostas joined one of Factor Bioscience’s spinoffs, Novellus Therapeutics, as an Associate Scientist after graduating with a Bachelor of Science degree in chemistry from Haverford College in 2018. Many from his graduating class went straight into graduate school or took technician positions in university labs, but Franklin decided to work in industry before pursuing his Ph.D
This year, we completed the construction of an ISO Class 7 cleanroom facility at our headquarters in Cambridge, Massachusetts. Our new facility is designed to produce cutting-edge mRNA and cellular medicines for all phases of clinical testing. In this facility, we will produce cells that have been reprogrammed and gene-edited using mRNA for anti-inflammatory, anti-cancer, and regenerative-medicine applications. We will also produce next-generation mRNA vaccines designed to elicit a robust and durable immune response against diverse pathogens. In addition to supporting our own projects, we are pleased to provide our partners with access to our cleanrooms to support and accelerate their clinical programs.